Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/03/14/2846504/0/en/HepaRegeniX-publishes-data-for-its-first-in-class-MKK4-inhibitor-HRX-215-for-the-treatment-of-acute-and-chronic-liver-diseases-in-Cell.html
https://www.accesswire.com/695217/HepaRegeniX-Appoints-Elias-Papatheodorou-as-New-Chairman-of-the-Board-of-Directors
https://pipelinereview.com/index.php/2021081078933/Small-Molecules/HepaRegeniX-initiates-first-in-man-Phase-1-trial-for-its-lead-MKK4-inhibitor-HRX-0215.html
https://pipelinereview.com/index.php/2021081078933/Small-Molecules/HepaRegeniX-initiates-first-in-man-Phase-1-trial-for-its-lead-MKK4-inhibitor-HRX-0215.html